
GVATAKEN
@VISLAMDSCAIP
Followers
1K
Following
26K
Media
2
Statuses
497
Joined April 2018
RT @FeliceGragnano: 🚀 PANTHER-2. Clopidogrel monotherapy is superior to aspirin monotherapy for MACCE prevention with no increase in the ri….
0
62
0
RT @tnvirjc: 📣Journal Club Alert📣.📅August 25th 2025📅.⏰7 PM EST / 4 PM PST⏰. Topic: STRIDE Trial: Semaglutide and walking capacity for sympt….
0
8
0
RT @KPVISLA: We are proud to announce that Vascular & Interventional is now an INDEPENDENT department at KP LAMC! Congrats to our chief Dr….
0
17
0
RT @JesusVictorJr: Love to see it. @KPVISLA pushing EVIS forward one medical student at a time 💪.
0
1
0
RT @WCVISociety: 🎯Get ready to ace your VIR sub-internship! Master more common consults like management of gastrointestinal bleeding, pulmo….
0
8
0
Colorectal cancer liver disease management @cirsesociety @ETF_IRtrainees @TraineesBSIR @IR_Juniors @Road2IR @ISVIRIndia @J_CIRCLE_IVR.
📣Next Journal Club📣.📆JUNE 9TH 2025.⏰7 PM EST/4 PM PST. Topic: COLLISION Trial: Surgery vs Thermal Ablation for Small Colorectal Liver Mets.Trial: Meijerink et al 2024. Presented by: @miseemily99 and @ellazzhang .Facilitated by: @fabianmaxlg . Scan QR to register
0
0
6
RT @WCVISociety: 🧠Join us for a conversation with VIR physicians who’ve made neurointervention part of their practice. We’ll explore their….
0
7
0
RT @WCVISociety: Reminder that our Acute Care Series talk on postpartum hemorrhage with Dr. Geronemus is tomorrow! Register using the link….
0
4
0
RT @WCVISociety: Mark your calendars for our next Match Series event, #VIR Resident Panel! Bring your questions and learn about clinical VI….
0
4
0
Invaluable lessons to be learned from the construction of multicenter clinical trials with clinical endpoints in the endovascular/interventional space @tnvirjc @IR_Juniors @IRadResearch @MCW_VIR @VIR_RUSH @WCVISociety @ETF_IRtrainees @J_CIRCLE_IVR @Warren_IR @ISVIRIndia.
🌟Join us for the new Landmark Trials speaker series from WCVIS spotlighting the pivotal studies that have shaped vascular and interventional radiology. 🔬Our first speaker, Dr. Vedantham, will discuss the ATTRACT trial with a special Q&A!.Register here:
0
7
17
RT @Rick_Pescatore: I’ve had the flashy saves. Diagnosed the zebras. Got the publications. But what actually matters is watching someone I….
0
6
0
Original Article: Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors (CABINET trial) . #Gastroenterology
0
2
11
RT @farkomd: This is incredibly sad. A bright and talented individual who always looked for answers via level 1 data. I’ve shared the panel….
0
8
0
RT @WCVISociety: 🥡Takeaways from the #medicalstudent #futureradres panel earlier by @SatyaMorar @ashleylamba1 ! .Thank you for joining us a….
0
2
0
How will this trial influence NCCN guidelines? @WCVISociety @tnvirjc @SIRRFS @SIRspecialists @TraineesBSIR @IR_Juniors @ISVIRIndia @cirsesociety.
It’s not always the 1st author of a landmark paper joins #Journal club. Discussing the landmark #Collision trail in @TheLancetOncol. Thank you Susan van der Lai @MartijnMr @MiamiVasc @SIRspecialists .@SIRRFS @SIR_ECS @BaptistHealthSF #CancerResearch
1
0
5
RT @WCVISociety: Hard to believe it's already been a week since #WCVIS2025! A huge thank you to our incredible organizers for making it all….
0
15
0
RT @ashleylamba1: So proud of our organizers and excited to see them make #WCVIS2026 even better! 🫶🏻.
0
2
0